Back to Work

Roger Perlmutter is to take the helm of Merck's research and development branch, the Wall Street Journal reports. Previously, Perlmutter was the executive vice president of research and development at Amgen until his retirement about a year ago and prior to joining Amgen he was worked in basic research at Merck. "By hiring Dr.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.